Home › Calculator › JCRRF Dividend Calculator 2026
JCRRF DRIP Calculator & Dividend Yield 2026
3.36% YieldHealthcareJCR Pharmaceuticals Co., Ltd. · OTC
Price: $3.73 · Annual div: $0.1252/share · Frequency: semi-annual · Payout ratio: 1% · Ex-div: 2027-03-30
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
JCRRF Dividend Yield
JCRRF (JCR Pharmaceuticals Co., Ltd.) has a dividend yield of 3.36%, based on an annual dividend of $0.1252 per share and a price of $3.73. Over the last 12 months it paid $0.1252 per share — a trailing yield of 3.36%. Dividends are paid semi-annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When JCRRF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
JCRRF Dividend History — Last 21 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2027-03-30Latest | 2027-03-30 | $0.0638 | — | — |
| 2026-09-30 | — | $0.0636 | 3.76% | $3.33 |
| 2026-03-30 | 2026-06-24 | $0.0616 | 4.70% | $4.17 |
| 2025-09-30 | 2025-12-05 | $0.0676 | 2.69% | $5.00 |
| 2025-03-31 | 2025-06-26 | $0.0667 | 3.00% | $4.57 |
| 2024-09-30 | 2024-12-06 | $0.0703 | 2.90% | $4.70 |
| 2024-03-28 | 2024-06-27 | $0.0660 | 2.30% | $9.04 |
| 2023-09-28 | 2023-12-08 | $0.0670 | 2.23% | $9.47 |
| 2023-03-30 | 2023-06-22 | $0.0753 | 1.17% | $12.38 |
| 2022-09-29 | 2022-12-09 | $0.0692 | 0.87% | $19.24 |
| 2022-03-30 | 2022-06-23 | $0.0984 | 1.05% | $17.95 |
| 2021-09-29 | 2021-12-10 | $0.0894 | 0.56% | $27.90 |
| 2021-03-30 | 2021-06-24 | $0.0680 | 0.33% | $33.85 |
| 2020-09-29 | 2020-12-10 | $0.0426 | — | — |
| 2020-03-30 | 2020-06-25 | $0.0393 | — | — |
| 2019-09-27 | 2019-12-10 | $0.0347 | — | — |
| 2019-03-27 | 2019-06-28 | $0.0385 | — | — |
| 2018-09-26 | 2018-12-10 | $0.0288 | — | — |
| 2018-03-28 | 2018-06-28 | $0.0330 | — | — |
| 2017-09-27 | 2017-12-08 | $0.0266 | — | — |
| 2017-03-29 | 2017-06-29 | $0.0270 | — | — |
About JCR Pharmaceuticals Co., Ltd. (JCRRF) — Dividend Analysis 2026
JCR Pharmaceuticals Co., Ltd., a specialized pharmaceutical company headquartered in Ashiya, Japan, and established in 1975, operates across the entire lifecycle of pharmaceutical products, regenerative medicines, and active drug substances. Its comprehensive activities in Japan encompass research, development, manufacturing, and both the import, export, and sale of these medical items. The company's current therapeutic offerings include several key treatments: GROWJECT, utilized for patients suffering from growth hormone deficiency and short stature. IZCARGO, specifically designed to address Mucopolysaccharidosis type II. Agalsidase Beta BS I.V. Infusion, administered for the management of Fabry disease. TEMCELL HS Inj, employed in the treatment of acute graft-versus-host disease. Furthermore, JCR Pharmaceuticals is actively expanding its pipeline with the development of Epoetin Alfa BS and Darbepoetin Alfa BS Injections, both intended to combat renal anemia. Beyond its pharmaceutical ventures, the firm also provides a selection of medical devices and laboratory instruments.
Similar dividend stocks to JCRRF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full JCRRF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open JCRRF position with:
🌍 JCRRF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold JCRRF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.36% | 0.56% | $336 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.86% | 0.06% | $286 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.69% | -0.11% | $269 / yr |
| 🇬🇧 UK ISA | 0% | 3.36% | 0.56% | $336 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.07% | 0.27% | $307 / yr |
| 🇨🇦 TFSA | 0% | 3.36% | 0.56% | $336 / yr |
| 🇨🇦 CA Taxable | 25% | 2.52% | -0.28% | $252 / yr |
| 🇦🇺 Super (pension) | 15% | 2.86% | 0.06% | $286 / yr |
| 🇦🇺 AU Taxable | 30% | 2.35% | -0.45% | $235 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.47% | -0.33% | $247 / yr |
| 🇫🇷 FR Taxable | 30% | 2.35% | -0.45% | $235 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 JCRRF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.13/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 JCRRF Dividend Payment Schedule
JCRRF pays quarterly — 4 times per year. Ex-div: 2027-03-30.
📊 JCRRF vs Healthcare Benchmarks
How JCRRF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for JCRRF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ JCRRF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare JCRRF with peers: JCRRF vs AGYTF · JCRRF vs AVNBF · JCRRF vs BJTRF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the JCRRF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
JCR Pharmaceuticals Co., Ltd. (JCRRF) is currently trading at $3.73, 21% below its 52-week high. The current dividend yield is 3.36% based on an annual payout of $0.1252 per share.
JCRRF (JCR Pharmaceuticals Co., Ltd.) — 3.36% Dividend Yield Analysis
JCR Pharmaceuticals Co., Ltd. (JCRRF) is a healthcare stock currently trading at $3.73 with a dividend yield of 3.36%. It pays an annual dividend of $0.1252 per share. The payout ratio of 1% suggests the dividend is well-covered by earnings. Over the past 5 years, JCRRF has grown its dividend at a compound annual rate of 18.1%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest JCRRF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the JCRRF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.